Saturday, December 20, 2025 | 01:33 AM ISTहिंदी में पढें
Stent Price Cut
NPPA to cap medicine prices to boost affordability, curb profiteering
The change could have financial implications for leading drug manufacturers like Abbott Laboratories, Bayer AG, and GlaxoSmithKline, among others
 "NPPA to cap medicine prices to boost affordability, curb profiteering")
Updated On : 10 May 2023 | 11:09 AM IST
After cap on stent prices, NPPA wants more devices under price control list
In a letter to the govt, regulator asks for inclusion of more devices 'as soon as possible'
 "After cap on stent prices, NPPA wants more devices under price control list")
Updated On : 07 Jun 2017 | 9:47 AM IST
US pat for stent price cut
AHA report believes NPPA's decision would also benefit domestic stent makers
Updated On : 23 May 2017 | 5:50 PM IST
